Altimmune, Inc. (ALT) Earnings
|
Expand Research on ALT
| Next EPS Date | 8/6/26 | EPS Growth Rate | +40.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +13.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.16 | N/A | N/A | $1.43K | N/A | N/A | N/A | ||
| 5/13/26 | Q126 | -$0.18 | -$0.24 | +$0.06 | N/A | $1K | N/A |  | | Details | |
| 3/5/26 | Q425 | -$0.27 | -$0.25 | -$0.02 | $26K | $625M | N/A | | | Details | |
| 11/6/25 | Q325 | -$0.21 | -$0.27 | +$0.06 | $5K | $2.14K | N/A | | | Details | |
| 8/12/25 | Q225 | -$0.27 | -$0.31 | +$0.04 | N/A | $833M | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.26 | -$0.38 | +$0.12 | $5K | N/A | N/A | | | Details | |
| 2/27/25 | Q424 | -$0.33 | -$0.34 | +$0.01 | N/A | $714M | N/A | | | Details | |
| 11/12/24 | Q324 | -$0.32 | -$0.36 | +$0.04 | N/A | $833M | N/A | | | Details |
